Sildenafil for Erectile Dysfunction: A Complete Guide for Indian Men
[1] [26][67] At clinically relevant concentrations, the manufacturer states that it is
- Sildenafil is available in different strengths to tailor treatment.
- It is often used in clinical settings for ED diagnosis and management.
- Men taking sildenafil should avoid heavy meals shortly before dosing.
- The drug's effectiveness can be influenced by age and overall health.
- Combining sildenafil with recreational drugs can be dangerous.
- Some users report that sildenafil enhances spontaneous sexual activity.
- It is important to only use sildenafil that has been prescribed by a healthcare provider.
- The medication’s cost varies based on brand, dosage, and pharmacy.
- Sildenafil may cause transient eye color changes due to blood vessel effects.
- Patients should keep track of dosage and side effects experienced.
unlikely that sildenafil will alter the clearance of drugs metabolized by these isoenzymes.
- Sildenafil is a popular choice for men seeking non-invasive ED therapy.
- It's important to have realistic expectations about sildenafil's effects.
- The medication does not increase libido but improves blood flow.
- Patients should limit alcohol consumption when using sildenafil.
- It is recommended to consult a doctor if ED persists despite medication.
- Sildenafil can be used as part of a comprehensive ED treatment plan.
- The medication should be taken approximately an hour before planned activity.
- Some patients experience no side effects at prescribed doses.
- Always confirm that sildenafil is stored properly to maintain efficacy.
- Report any unusual symptoms, such as chest pain or vision loss, immediately.
A minor route of metabolism of sildenafil is through the CYP2C9 isoenzyme.
Online Sildenafil Prescription
Patients should be advised sildenafil pink pill that use of sildenafil provides no protection against sexually transmitted diseases and they should be counseled regarding protective measures to guard against such transmission. Sildenafil for ED (e.g., Viagra®) is not indicated for use in females. [1] There are no data with use in pregnant women to inform any drug-associated risks for adverse developmental outcomes. No evidence of teratogenicity, embryotoxicity, or fetotoxicity was observed in rats and rabbits receiving up to 200 mg/kg daily of sildenafil during organogenesis. [1] These doses in rats and rabbits represent about 16 and 32 times, respectively, the maximum recommended human dose (MRHD) for the treatment of ED on a mg/m2 basis in a 50-kg patient.
Other Medical Problems
[1] No adverse effects were observed Iin a prenatal and postnatal development study in rats receiving 30 mg/kg daily for 36 days (equivalent to 2-times the MRHD on a mg/m2 basis in a 50-kg subject). [1] Limited data indicate that sildenafil and its active metabolite are present in human milk. [1] There is no information about the effects of sildenafil on the breastfed infant or on milk production. Reproduction studies revealed no evidence of impaired fertility at sildenafil dosages up to 60 mg/kg daily (for 36 days in female rats and 102 days in male rats), a dosage representing more than 25 times the human male AUC. [1] No effect on sperm motility or morphology was noted after a single 100-mg oral sildenafil dose in healthy human adults. [1][67][250] Although some clinicians state that the possibility of an interaction
- Sildenafil may improve confidence and sexual satisfaction in men with ED.
- The medication is also being researched for pulmonary hypertension treatment.
- Common side effects include dizziness, upset stomach, and vision changes.
- Rare side effects can include priapism, a painful prolonged erection.
- Alcohol can interfere with sildenafil's effectiveness and increase side effects.
- Patients should disclose any heart conditions before using sildenafil.
- Sildenafil may interact with other medications such as alpha-blockers.
- It is not suitable for individuals with severe liver or kidney problems.
- Taking large doses does not necessarily improve efficacy and increases risk.
- Always follow the prescribed dosage and discontinue if adverse effects occur.
between sildenafil and drugs metabolized by CYP2C9 should be considered, there
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Viagra Generic | 100mg | 360 + 10 Pills | 330.21€ 314.49€ | |
| Viagra Generic | 100mg | 90 + 6 Pills | 129.02€ 122.88€ | |
| Kamagra Polo | 100mg | 32 Pills | 125.88€ 119.89€ | |
| Kamagra Soft Tabs | 100mg | 180 + 8 Pills | 425.45€ 405.19€ | |
| Viagra Generic | 200mg | 360 + 10 Pills | 481.98€ 459.03€ | |
| Viagra Generic | 200mg | 10 Pills | 40.96€ 39.01€ | |
| Viagra Generic | 25mg | 90 + 6 Pills | 105.03€ 100.03€ | |
| Viagra Generic | 25mg | 270 + 8 Pills | 184.26€ 175.49€ | |
| Kamagra | 100mg | 20 Pills | 86.09€ 81.99€ | |
| Viagra Generic | 150mg | 90 + 6 Pills | 147.18€ 140.17€ | |
| Viagra Generic | 25mg | 360 + 10 Pills | 213.68€ 203.50€ |
was no evidence of appreciable inhibition of CYP2C9-mediated (e.g., tolbutamide, warfarin)
Medical uses
In patients with severe renal impairment (creatinine clearance less than 30 mL/minute), consider reducing the initial dose of sildenafil to 25 mg.[1] The most common adverse effects (>=2%) of sildenafil used for the treatment of ED include headache, flushing, dyspepsia, abnormal vision, nasal congestion, back pain, myalgia, nausea, dizziness, and rash. Sildenafil is metabolized principally via hepatic cytochrome P-450 (CYP) microsomal isoenzymes 3A4 (major route) and 2C9 (minor route). [1][91][131] Inhibitors and sildenafil citrate 100 mg inducers of these isoenzymes may reduce or increase sildenafil clearance, respectively. In vitro studies indicate that sildenafil is a weak inhibitor of the CYP isoenzymes 1A2, 2C9, 2C19, 2D6, 2E1, and 3A4. [1][26][67][250] Sildenafil is not expected to affect the pharmacokinetics of substrates of these CYP enzymes at clinically relevant concentrations.
General drug facts
The possibility that any drug that inhibits CYP3A4 may interact with sildenafil should be considered. [1][67] In some cases, a reduction in sildenafil dosage is recommended. Clinically important pharmacokinetic interactions have been reported with several antiretroviral agents that inhibit CYP3A4 (e.g., ritonavir, saquinavir) and can potentially result in an increase in sildenafil-associated adverse effects. The possibility that any drug that induces CYP3A4 may interact with sildenafil should be considered. Pharmacokinetic data from patients in clinical trials showed no effect on sildenafil pharmacokinetics when the drug was used concomitantly with CYP2D6 inhibitors such as selective serotonin-reuptake inhibitors (SSRIs) or tricyclic antidepressants. or CYP3A4-mediated (e.g., ritonavir, saquinavir) metabolism by sildenafil in clinical studies.
- Sildenafil is a phosphodiesterase type 5 (PDE5) inhibitor.
- The drug was first approved by the FDA in 1998.
- It can be purchased online but requires a prescription in most countries.
- Generic versions of sildenafil are typically cheaper than brand-name Viagra.
- Proper storage involves keeping it at room temperature away from moisture.
- Sildenafil does not protect against sexually transmitted diseases.
- Lifestyle changes like exercise and healthy eating can enhance results.
- Combining sildenafil with other ED treatments should be discussed with a doctor.
- It's important to inform your doctor about all medications you take.
- Sildenafil is not an aphrodisiac and requires sexual stimulation to work.
**Antacids:**Single doses of an aluminum and magnesium hydroxide-containing antacid did not affect the oral bioavailability of sildenafil.
| Study/Survey | Percentage of Effectiveness | Sample Size | Notes |
|---|---|---|---|
| Clinical Trial A | 70-80% | 500 | Erectile improvement observed |
| User Survey B | 75% | 1,200 | Satisfaction rate |
| Meta-Analysis C | 78% | Various | Consistent efficacy |
Cimetidine: Plasma sildenafil concentrations increased by approximately 56% in healthy individuals who received a single 50-mg oral dose of the drug concomitantly with a single oral dose of cimetidine (800 mg), a nonspecific inhibitor of the cytochrome P-450 mixed-function oxidase system.
What should I know about storage and disposal of this medication?
Sildenafil for ED (e.g., Viagra®) is not indicated for use in pediatric patients. [1] The manufacturer states that safety and efficacy of sildenafil in children have not been established. The AUC of free (unbound) sildenafil and its active N-desmethyl metabolite were 45 and 57% higher, respectively, in healthy volunteers >=65 years of age compared to healthy volunteers 18-45 years of age. [1] Clinical studies included patients >=65 years of age (18%) and >=75 years of age (2%); no overall differences in safety and efficacy were observed between older (>=65 years of age) and younger (<65 years of age) patients[1] Because higher plasma levels may increase the incidence of adverse reactions, consider reducing the initial sildenafil dosage to 25 mg in older patients. In patients with hepatic cirrhosis (Child-Pugh class A or B), sildenafil clearance is reduced, resulting in increased AUC (by 85%) and peak plasma concentrations (by 47%) compared with values observed in age-matched healthy adults.
About Sildenafil (Viagra®)
[1][31][131] The effect of severe hepatic impairment on the pharmacokinetics of sildenafil has not been evaluated to date. In patients with any degree of hepatic impairment (e.g. cirrhosis), consider reducing the initial dose of sildenafil to 25 mg.[1] In patients with mild (creatinine clearance 50-80 mL/minute) or moderate (creatinine clearance 30-49 mL/minute) renal impairment, the pharmacokinetics of a single 50-mg oral dose of sildenafil are not altered. [1][31][131] However, in patients with severe (creatinine clearance less than 30 mL/minute) renal impairment, sildenafil clearance is reduced, resulting in AUC and peak plasma concentrations of the parent drug that are approximately double those in age-matched healthy adults. [1][31][67][131] In addition, AUC and peak plasma concentrations of the N-demethylated metabolite are 200 and 79% greater, respectively, than those in individuals with normal renal function. [1][67] Population pharmacokinetic analysis of data from clinical trials indicates
| Brand Name | Manufacturer | Price Range (per pill) | Availability | Notes |
|---|---|---|---|---|
| Viagra | Pfizer | $10 - $30 | Widely available | Most popular brand |
| Kamagra | Ajanta Pharma | $2 - $8 | Online, some stores | Cheaper alternative |
| Sildenafil Citrate | Generic | $1 - $5 | Online, pharmacies | Generic form available |
that cimetidine reduces sildenafil clearance when these drugs are administered concomitantly.
What other drugs will affect sildenafil?
In patients who exhibit hemodynamic instability while receiving an α-adrenergic blocking agent, use caution. [1] Patients should be stable on an α-adrenergic blocking agent prior to initiation of sildenafil, and sildenafil should be administered at the lowest possible dose. [1] In patients receiving an optimal dose of sildenafil, initiate the α-adrenergic blocking agent at the lowest dose. Concomitant administration of ritonavir substantially increases serum concentrations of sildenafil (11-fold increase in AUC). [1] Data are limited; decreased blood pressure, syncope, and prolonged erection have been reported in some healthy volunteers exposed to high doses of sildenafil (200-800 mg).
Does sildenafil cause different side effects in females?
[1] Use sildenafil with caution in patients receiving ritonavir; reduced sildenafil dosage is recommended to decrease the chance of adverse reactions to sildenafil. Bleeding events have been reported in patients taking sildenafil for ED. [1] In patients with bleeding disorders or active peptic ulcers, sildenafil should be used with caution since safety of the drug has not been established. [1][27][33][67][131] The possibility that sildenafil could potentiate the effects of certain other drugs exhibiting antiplatelet activity should be considered. Safety and efficacy have not been established for use of sildenafil in combination with other PDE type 5 inhibitors or other treatments for ED; such combinations may further lower blood pressure and are not recommended. [1][139] Some clinicians recommend that a lower initial sildenafil dose (25 mg) be considered in patients with ED receiving cimetidine.
How to Take Sildenafil Correctly for Erectile Dysfunction
Although at greater risk for NAION compared to the general population, evidence is insufficient to support screening for "crowded" optic disc in prospective users of PDE type 5 inhibitors for the treatment of ED. Sildenafil should be used with caution in patients with retinitis pigmentosa, a retinal disorder that may be accompanied by a genetic disorder of retinal phosphodiesterases in some patients, since data establishing the safety and efficacy of the drug in these patients currently are lacking. Sudden decrease or loss of hearing, with or without concomitant vestibular manifestations (e.g., tinnitus, dizziness), has been reported in temporal association with use of PDE type 5 inhibitors, including sildenafil. [1] It is unclear whether these otic effects are directly related to PDE type 5 inhibitors or attributed to other underlying risk factors for hearing loss, a combination of these factors, or to other factors. Patients should discontinue sildenafil and seek medical attention immediately if sudden hearing loss or decreased hearing occurs.
Azole Antifungals
Prolonged erection (exceeding 4 hours) and priapism (painful erection exceeding 6 hours) have been reported infrequently during postmarketing surveillance with sildenafil. [1][31][127][131][139][146][147] Because of the risk of penile tissue damage and permanent loss of potency if priapism is not treated immediately, patients should be warned to seek immediate medical attention if an erection persists for longer than 4 hours. Sildenafil should be used with caution in patients with anatomic deformation of the penis (such as angulation, cavernosal fibrosis, or Peyronie's disease) and in patients who have conditions that may predispose them to priapism (e.g., sickle cell anemia, multiple myeloma, leukemia). Caution is advised when PDE type 5 inhibitors are co-administered with α-adrenergic blocking agents; blood pressure may be lowered significantly and in some patients, symptomatic hypotension (e.g., dizziness, lightheadedness, fainting) may occur. [1] Patients who demonstrate hemodynamic instability during therapy with an α-adrenergic blocking agent alone are at increased risk for symptomatic hypotension with concomitant use of a PDE type 5 inhibitor.